| top of page |
| Details of the target gene |
| Gene Model of Rodent Parasite |
PBANKA_1136700
|
| Gene Model P. falciparum ortholog |
PF3D7_1360500
|
| Gene product | guanylyl cyclase beta |
| Gene product: Alternative name | GCβ, guanylyl cyclase beta |
| top of page |
| Details of the genetic modification |
| Inducable system used | No |
| Additional remarks inducable system |
|
| Type of plasmid/construct used | Plasmid double cross-over |
| PlasmoGEM (Sanger) construct/vector used | No |
| Modified PlasmoGEM construct/vector used | No
|
| Plasmid/construct map |
|
| Plasmid/construct sequence |
|
| Restriction sites to linearize plasmid |
ClaI/EcoRI
|
| Partial or complete disruption of the gene | Partial |
| Additional remarks partial/complete disruption |
Most of the Transmembrane domain (TM) and both catalytic sites of guanylate cyclase were disrupted. Part of the TM remained
|
| Selectable marker used to select the mutant parasite | tgdhfr |
| Promoter of the selectable marker | pbdhfr |
| Selection (positive) procedure | pyrimethamine |
| Selection (negative) procedure | No |
| Additional remarks genetic modification | |
| Additional remarks selection procedure | |
Primer information: Primers used for amplification of the target sequences 
Primer information: Primers used for amplification of the target sequences
| Sequence Primer 1 | AAGCTTCATTTATCCAATACCCTG |
| Additional information primer 1 | GCß–F1-HindIII; 5' |
| Sequence Primer 2 | AAGCTTATTTCCAATAAGTACCC |
| Additional information primer 2 | GCß-R1-HindIII; 5' |
| Sequence Primer 3 | GAATTCGTGTGTTGGAGGAATTATAG |
| Additional information primer 3 | GCß–F2-EcoRI; 3' |
| Sequence Primer 4 | GGATCCTCGTAGTTTATAATTTTGG |
| Additional information primer 4 | GCß–R2-BamHI; 3' |
| Sequence Primer 5 | |
| Additional information primer 5 | |
| Sequence Primer 6 | |
| Additional information primer 6 | |
|
| top of page |